Vimarsana
Biggest News Aggregation in the World

Janec Parker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janec Parker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janec Parker Today - Breaking & Trending Today

Intravenous Vitamin C for Patients Hospitalized With COVID-19 - Vimarsana News

Intravenous Vitamin C for Patients Hospitalized With COVID-19

Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critica

Opinion | How the Bidens Treat Hunter's Daughter - The New York Times - Vimarsana News

Opinion | How the Bidens Treat Hunter's Daughter - The New York Times

Readers discuss a column by Maureen Dowd critical of the president. Also: Serving gay people; faith communities; Indiana Jones; Ron DeSantis and Goofy.

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial examines the effect of initiation of a renin-angiotensin system inhibitor (ACE inhibitor or an angiotensin receptor blocker) on t

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA

This secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-te

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial assesses the effect of treatment with an antiplatelet agent vs no antiplatelet therapy on days alive and free of intensive care u